Applications: |
Immunodepletion/Immunocompetition |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
MYLK3 Blocking Peptide for STJ501841 is synthetically produced from the 10-60 sequence and is suitable for use in western blot applications. |
Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
MYLK3 |
Gene ID: |
91807 |
Uniprot ID: |
MYLK3_HUMAN |
Immunogen Region: |
10-60 |
Specificity: |
This blocking peptide is recommended for use in combination with MYLK3 antibody, STJ501841 |
Immunogen: |
Synthetic peptide taken within amino acid region 10-60 on human Myosin light chain kinase 3 protein. |
Tissue Specificity | Restricted to heart. |
Post Translational Modifications | Phosphorylated on serine residues. |
Function | Kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes and increases cardiomyocyte contractility. |
Peptide Name | Myosin Light Chain Kinase 3Cardiac-Mybp-C-Associated Ca/Cam KinaseCardiac-Mlck |
Cellular Localisation | Cytoplasm |
Alternative Peptide Names | Myosin Light Chain Kinase 3 proteinCardiac-Mybp-C-Associated Ca/Cam Kinase proteinCardiac-Mlck proteinMYLK3 proteinMLCK protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance